| ASSET | QUARTER | % RETURN |
|---|---|---|
Avalon GloboCare (ALBT) | Q1 2018 | 2,259,275% |
GT Biopharma (GTBP) | Q1 2018 | 21,529.84% |
Delcath Systems (DCTH) | Q1 2018 | 13,927.24% |
SurgePays (SURG) | Q1 2018 | 2,005.26% |
Quantum Computing (QUBT) | Q1 2018 | 1,400% |
TON Strategy (TONX) | Q1 2018 | 1,350% |
Q/C Technologies (QCLS) | Q1 2018 | 497.12% |
Arcadia Biosciences (RKDA) | Q1 2018 | 328.75% |
BlueLinx (BXC) | Q1 2018 | 233.57% |
INVO Fertility (IVF) | Q1 2018 | 220% |
Kaival Brands Innovations (KAVL) | Q1 2018 | 220% |
Nutriband (NTRB) | Q1 2018 | 199.4% |
Aemetis (AMTX) | Q1 2018 | 194.37% |
American Resources Corp Class A (AREC) | Q1 2018 | 168.68% |
Acm Research (ACMR) | Q1 2018 | 134.29% |
Beam Global (BEEM) | Q1 2018 | 132.03% |
Geron (GERN) | Q1 2018 | 130.98% |
ProMIS Neurosciences (PMN) | Q1 2018 | 125% |
POET Technologies (POET) | Q1 2018 | 123.53% |
Atara Biotherapeutics (ATRA) | Q1 2018 | 117.27% |
Odyssey Marine Exploration (OMEX) | Q1 2018 | 116.78% |
Immuron Ltd ADR (IMRN) | Q1 2018 | 116.35% |
Daxor (DXR) | Q1 2018 | 116.32% |
My Size (MYSZ) | Q1 2018 | 112.12% |
Tandem Diabetes Care (TNDM) | Q1 2018 | 111.06% |
